Synthetic Pathways to Non-Psychotropic Phytocannabinoids as Promising Molecules to Develop Novel Antibiotics: A Review
Due to the rapid emergence of multi drug resistant (MDR) pathogens against which current antibiotics are no longer functioning, severe infections are becoming practically untreatable. Consequently, the discovery of new classes of effective antimicrobial agents with novel mechanism of action is becom...
Main Authors: | Silvana Alfei, Gian Carlo Schito, Anna Maria Schito |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/7/1889 |
Similar Items
-
Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from <i>Cannabis sativa</i> L. Promising Compounds?
by: Ersilia Nigro, et al.
Published: (2021-05-01) -
Biosynthesis of Phytocannabinoids and Structural Insights: A Review
by: Rasiravathanahalli Kaveriyappan Govindarajan, et al.
Published: (2023-03-01) -
Pharmacological and Toxicological Effects of Phytocannabinoids and Recreational Synthetic Cannabinoids: Increasing Risk of Public Health
by: Vidyasagar Naik Bukke, et al.
Published: (2021-09-01) -
Mass Spectrometry-Based Metabolomics of Phytocannabinoids from Non-Cannabis Plant Origins
by: Sarana Rose Sommano, et al.
Published: (2022-05-01) -
Terpenoids and Phytocannabinoids Co-Produced in <i>Cannabis Sativa</i> Strains Show Specific Interaction for Cell Cytotoxic Activity
by: Dvora Namdar, et al.
Published: (2019-08-01)